Cargando…
Is liquid biopsy mature enough for the diagnosis of Alzheimer’s disease?
The preclinical diagnosis and clinical practice for Alzheimer’s disease (AD) based on liquid biopsy have made great progress in recent years. As liquid biopsy is a fast, low-cost, and easy way to get the phase of AD, continual efforts from intense multidisciplinary studies have been made to move the...
Autores principales: | Gong, Xun, Zhang, Hantao, Liu, Xiaoyan, Liu, Yi, Liu, Junlin, Fapohunda, Funmilayo O., Lü, Peng, Wang, Kun, Tang, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389010/ https://www.ncbi.nlm.nih.gov/pubmed/35992602 http://dx.doi.org/10.3389/fnagi.2022.977999 |
Ejemplares similares
-
Editorial: Integrative multi-omics for diagnosis, treatments, and drug discovery of aging-related neuronal diseases
por: Shan, Chaofan, et al.
Publicado: (2022) -
Crosstalk between regulatory non-coding RNAs and oxidative stress in Parkinson’s disease
por: Zhang, Hantao, et al.
Publicado: (2022) -
Application of High-Throughput Sequencing on the Chinese Herbal Medicine for the Data-Mining of the Bioactive Compounds
por: Liu, Xiaoyan, et al.
Publicado: (2022) -
Editorial: Computational tools in inferring cancer tissue-of-origin and molecular classification towards personalized cancer therapy, volume III
por: Guo, Yinglu, et al.
Publicado: (2022) -
Editorial: Artificial intelligence in digital pathology image analysis
por: Liu, Yi, et al.
Publicado: (2023)